Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
244 | 3 | IMMUNOLOGY//PHAGE DISPLAY//BIOSIMILAR | 47231 |
1376 | 2 | BIOSIMILAR//FCRN//ANTIBODY DRUG CONJUGATE | 8436 |
10180 | 1 | FCRN//NEONATAL FC RECEPTOR//TARGET MEDIATED DRUG DISPOSITION | 1116 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | FCRN | authKW | 3072380 | 12% | 80% | 136 |
2 | NEONATAL FC RECEPTOR | authKW | 1473995 | 6% | 78% | 67 |
3 | TARGET MEDIATED DRUG DISPOSITION | authKW | 579233 | 3% | 71% | 29 |
4 | NEONATAL FC RECEPTOR FCRN | authKW | 533513 | 2% | 82% | 23 |
5 | FCGRT | authKW | 228736 | 1% | 90% | 9 |
6 | ROSENSTIEL BASIC BIOMED SCI | address | 225906 | 1% | 67% | 12 |
7 | PHARMACOKINET PHARMACODYNAM SCI | address | 169412 | 2% | 33% | 18 |
8 | MABS | journal | 159532 | 6% | 8% | 67 |
9 | IGG CATABOLISM | authKW | 153744 | 1% | 78% | 7 |
10 | ANTIBODY PHARMACOKINETICS | authKW | 145229 | 1% | 86% | 6 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3401 | 33% | 0% | 370 |
2 | Immunology | 2727 | 25% | 0% | 274 |
3 | Medicine, Research & Experimental | 628 | 10% | 0% | 111 |
4 | Reproductive Biology | 484 | 4% | 0% | 49 |
5 | Biochemistry & Molecular Biology | 148 | 14% | 0% | 156 |
6 | Toxicology | 125 | 4% | 0% | 44 |
7 | Developmental Biology | 79 | 2% | 0% | 23 |
8 | Cell Biology | 73 | 6% | 0% | 70 |
9 | Chemistry, Medicinal | 50 | 3% | 0% | 31 |
10 | Biochemical Research Methods | 32 | 3% | 0% | 31 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ROSENSTIEL BASIC BIOMED SCI | 225906 | 1% | 67% | 12 |
2 | PHARMACOKINET PHARMACODYNAM SCI | 169412 | 2% | 33% | 18 |
3 | DRUG DISPOSIT DEV COMMERCIALIZAT | 72608 | 1% | 43% | 6 |
4 | WM KECK CELLULAR VISUALIZAT | 67221 | 1% | 24% | 10 |
5 | DAVIS HEART LUNG 012K | 63537 | 0% | 75% | 3 |
6 | CLIN PHARMACOL ONCOL BUSINESS UNIT | 56479 | 0% | 100% | 2 |
7 | DAVIS HEART LUNG 425 | 56479 | 0% | 100% | 2 |
8 | RILBIO CO LTD | 56479 | 0% | 100% | 2 |
9 | ROSENTIEL BASIC BIOMED SCI | 56479 | 0% | 100% | 2 |
10 | TRANSLAT MODELING SIMULAT | 56479 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MABS | 159532 | 6% | 8% | 67 |
2 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 63100 | 3% | 6% | 37 |
3 | AAPS JOURNAL | 26324 | 3% | 3% | 34 |
4 | PHARMACEUTICAL RESEARCH | 4692 | 3% | 0% | 37 |
5 | BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY | 4407 | 1% | 2% | 9 |
6 | CLINICAL PHARMACOKINETICS | 3742 | 2% | 1% | 18 |
7 | JOURNAL OF CLINICAL PHARMACOLOGY | 2671 | 2% | 0% | 23 |
8 | PROTEIN ENGINEERING DESIGN & SELECTION | 2562 | 1% | 1% | 10 |
9 | DRUG METABOLISM AND PHARMACOKINETICS | 2388 | 1% | 1% | 8 |
10 | PLACENTA | 1997 | 2% | 0% | 17 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FCRN | 3072380 | 12% | 80% | 136 | Search FCRN | Search FCRN |
2 | NEONATAL FC RECEPTOR | 1473995 | 6% | 78% | 67 | Search NEONATAL+FC+RECEPTOR | Search NEONATAL+FC+RECEPTOR |
3 | TARGET MEDIATED DRUG DISPOSITION | 579233 | 3% | 71% | 29 | Search TARGET+MEDIATED+DRUG+DISPOSITION | Search TARGET+MEDIATED+DRUG+DISPOSITION |
4 | NEONATAL FC RECEPTOR FCRN | 533513 | 2% | 82% | 23 | Search NEONATAL+FC+RECEPTOR+FCRN | Search NEONATAL+FC+RECEPTOR+FCRN |
5 | FCGRT | 228736 | 1% | 90% | 9 | Search FCGRT | Search FCGRT |
6 | IGG CATABOLISM | 153744 | 1% | 78% | 7 | Search IGG+CATABOLISM | Search IGG+CATABOLISM |
7 | ANTIBODY PHARMACOKINETICS | 145229 | 1% | 86% | 6 | Search ANTIBODY+PHARMACOKINETICS | Search ANTIBODY+PHARMACOKINETICS |
8 | SERUM HALF LIFE | 117652 | 1% | 42% | 10 | Search SERUM+HALF+LIFE | Search SERUM+HALF+LIFE |
9 | TMDD | 115305 | 1% | 58% | 7 | Search TMDD | Search TMDD |
10 | ALBUDAB | 84718 | 0% | 100% | 3 | Search ALBUDAB | Search ALBUDAB |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |